Captopril is an FDA-approved medication used in the management of hypertension, left ventricular dysfunction after myocardial infarction, and diabetic nephropathy. Off-label indications include acute hypertensive crisis and Raynaud phenomenon. This activity reviews the mechanism of action, adverse event profile, toxicity, dosing, pharmacodynamics, and monitoring of captopril, pertinent for clinicians and other interprofessional team members to be familiar with to ensure appropriate administration of captopril.

**Objectives:**
- Describe the mechanism of action of captopril.
- Identify the FDA and off-label indications for captopril.
- Review the potential adverse effects of captopril.
- Summarize the importance of collaboration and communication among interprofessional team members to improve outcomes and treatment efficacy for patients receiving treatment with captopril.